(MS) Morgan Stanley - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US6174464486

Wealth Management, Investment Management, Institutional Securities

Stock: Investment Banking & Brokerage
Age 32.9y

MCap 305,267m
Avg Vol 4.54M (821M USD)

Beta 1.291
Volatility 26.91%

EPS (Earnings per Share)

EPS CAGR: 7.83%
EPS Trend: 67.7%

Last SUE: 1.19
Qual. Beats: 8

Revenue

Rev. CAGR: 21.71%
Rev. Trend: 93.9%

Last SUE: 3.64
Qual. Beats: 3

Dividends

Dividend Yield	2.78%
Yield on Cost 5y	6.02%
Yield CAGR 5y	16.36%
Payout Consistency	90.1%
Payout Ratio	31.0%

Risk via 5d forecast
Volatility	26.9%
Value at Risk 5%th	40.1%
Relative Tail Risk	-9.50%

Reward TTM
Sharpe Ratio	1.20
Alpha	26.78
CAGR/Max DD	1.01

Character TTM
Hurst Exponent	0.405
Beta	1.291
Beta Downside	1.443

Drawdowns 3y
Max DD	29.24%
Mean DD	7.84%
Median DD	5.78%

Description: MS Morgan Stanley December 01, 2025

Morgan Stanley (NYSE: MS) is a diversified financial services firm that operates across Institutional Securities, Wealth Management, and Investment Management. It delivers capital-raising, underwriting, M&A advisory, and project-finance services to governments, corporations, and high-net-worth individuals worldwide.

In the Institutional Securities segment, the bank combines equity and fixed-income sales, prime brokerage, and market-making. Recent data show that net revenue in Q3 2024 rose 5% YoY to roughly $13.5 billion, driven largely by higher trading volumes and a 12% increase in underwriting fees.

The Wealth Management arm, anchored in North America and expanding in Asia, now oversees about $2.5 trillion in client assets, with a 2024-23 net new assets inflow of $120 billion, reflecting strong demand for discretionary portfolio management amid volatile equity markets.

Investment Management provides multi-asset solutions to pension plans, sovereign wealth funds, and endowments, managing roughly $1.1 trillion in assets. A key sector driver is the ongoing shift toward ESG-focused allocations, which has lifted the firm’s alternatives AUM by 8% year-over-year.

Given the firm’s exposure to interest-rate cycles and global M&A activity, analysts should monitor the Federal Reserve policy path and cross-border deal flow as primary risk factors.

For a deeper, data-driven look at Morgan Stanley’s valuation dynamics, consider exploring the ValueRay platform’s quantitative models.

Piotroski VR‑10 (Strict, 0-10) 3.5

Net Income (16.86b TTM) > 0 and > 6% of Revenue (6% = 6.97b TTM)

FCFTA -0.00 (>2.0%) and ΔFCFTA 2.11pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue -537.4% (prev -244.1%; Δ -293.3pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA -0.00 (>3.0%) and CFO -3.68b <= Net Income 16.86b (YES >=105%, WARN >=100%)

Net Debt (414.62b) to EBITDA (26.56b) ratio: 15.61 <= 3.0 (WARN <= 3.5)

Current Ratio 0.26 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (1.59b) change vs 12m ago -0.93% (target <= -2.0% for YES)

Gross Margin 57.48% (prev 55.61%; Δ 1.88pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 9.00% (prev 8.49%; Δ 0.51pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 0.45 (EBITDA TTM 26.56b / Interest Expense TTM 49.02b) >= 6 (WARN >= 3)

Altman Z'' -2.62

(A) -0.46 = (Total Current Assets 216.31b - Total Current Liabilities 840.30b) / Total Assets 1364.81b

(B) 0.08 = Retained Earnings (Balance) 112.43b / Total Assets 1364.81b

(D) 0.0 = Book Value of Equity 0.0 / Total Liabilities 1253.76b

Total Rating: -2.62 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 50.79

1. Piotroski 3.50pt

2. FCF Yield -0.94%

3. FCF Margin -5.81%

4. Debt/Equity 3.77

5. Debt/Ebitda 15.61

6. ROIC - WACC (= -2.01)%

7. RoE 15.70%

8. Rev. Trend 93.93%

9. EPS Trend 67.67%

What is the price of MS shares?

As of January 19, 2026, the stock is trading at USD 189.09 with a total of 7,181,251 shares traded.
Over the past week, the price has changed by +1.35%, over one month by +9.33%, over three months by +17.45% and over the past year by +41.58%.

Is MS a buy, sell or hold?

Morgan Stanley has received a consensus analysts rating of 3.42. Therefor, it is recommend to hold MS.

Strong Buy: 5
Buy: 1
Hold: 17
Sell: 1
Strong Sell: 0

What are the forecasts/targets for the MS price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	184.6	-2.4%
Analysts Target Price	184.6	-2.4%
ValueRay Target Price	241.3	27.6%

MS Fundamental Data Overview January 17, 2026

P/E Trailing = 19.6133
P/E Forward = 17.0648
P/S = 4.4544
P/B = 2.8671
P/EG = 1.4453
Revenue TTM = 116.11b USD
EBIT TTM = 21.95b USD
EBITDA TTM = 26.56b USD
Long Term Debt = 332.20b USD (from longTermDebt, two quarters ago)
Short Term Debt = 82.43b USD (from shortTermDebt, two quarters ago)
Debt = 414.62b USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = 414.62b USD (using Total Debt 414.62b, CCE unavailable)
Enterprise Value = 719.89b USD (305.27b + Debt 414.62b - (null CCE))
Interest Coverage Ratio = 0.45 (Ebit TTM 21.95b / Interest Expense TTM 49.02b)
EV/FCF = -106.7x (Enterprise Value 719.89b / FCF TTM -6.75b)
FCF Yield = -0.94% (FCF TTM -6.75b / Enterprise Value 719.89b)
FCF Margin = -5.81% (FCF TTM -6.75b / Revenue TTM 116.11b)
Net Margin = 14.52% (Net Income TTM 16.86b / Revenue TTM 116.11b)
Gross Margin = 57.48% ((Revenue TTM 116.11b - Cost of Revenue TTM 49.37b) / Revenue TTM)
Gross Margin QoQ = 59.60% (prev 56.85%)
Tobins Q-Ratio = 0.53 (Enterprise Value 719.89b / Total Assets 1364.81b)
Interest Expense / Debt = 2.92% (Interest Expense 12.10b / Debt 414.62b)
Taxrate = 23.19% (1.34b / 5.76b)
NOPAT = 16.86b (EBIT 21.95b * (1 - 23.19%))
Current Ratio = 0.26 (Total Current Assets 216.31b / Total Current Liabilities 840.30b)
Debt / Equity = 3.77 (Debt 414.62b / totalStockholderEquity, two quarters ago 109.96b)
Debt / EBITDA = 15.61 (Net Debt 414.62b / EBITDA 26.56b)
Debt / FCF = -61.45 (negative FCF - burning cash) (Net Debt 414.62b / FCF TTM -6.75b)
Total Stockholder Equity = 107.37b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.31% (Net Income 16.86b / Total Assets 1364.81b)
RoE = 15.70% (Net Income TTM 16.86b / Total Stockholder Equity 107.37b)
RoCE = 4.99% (EBIT 21.95b / Capital Employed (Equity 107.37b + L.T.Debt 332.20b))
RoIC = 3.81% (NOPAT 16.86b / Invested Capital 442.94b)
WACC = 5.82% (E(305.27b)/V(719.89b) * Re(10.67%) + D(414.62b)/V(719.89b) * Rd(2.92%) * (1-Tc(0.23)))
Discount Rate = 10.67% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.05%
Fair Price DCF = unknown (Cash Flow -6.75b)
EPS Correlation: 67.67 | EPS CAGR: 7.83% | SUE: 1.19 | # QB: 8
Revenue Correlation: 93.93 | Revenue CAGR: 21.71% | SUE: 3.64 | # QB: 3
EPS next Quarter (2026-03-31): EPS=2.85 | Chg30d=+0.035 | Revisions Net=+8 | Analysts=13
EPS current Year (2026-12-31): EPS=10.73 | Chg30d=+0.175 | Revisions Net=+16 | Growth EPS=+5.1% | Growth Revenue=+5.5%
EPS next Year (2027-12-31): EPS=11.92 | Chg30d=+0.148 | Revisions Net=+9 | Growth EPS=+11.0% | Growth Revenue=+5.6%

Additional Sources for MS Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle